The Antibiotic Kitasamycin—A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?
- DOI
- 10.3390/pharmaceutics15020329
- Published
- 2023-01-18
- Container
- Pharmaceutics
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics15020329,
title = {The Antibiotic Kitasamycin—A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?},
author = {Katharina A. Sterenczak and Georg Fuellen and Anselm Jünemann and Rudolf F. Guthoff and Oliver Stachs and Thomas Stahnke},
year = {2023},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics15020329},
url = {https://doi.org/10.3390/pharmaceutics15020329}
}RIS
TY - JOUR TI - The Antibiotic Kitasamycin—A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery? AU - Katharina A. Sterenczak AU - Georg Fuellen AU - Anselm Jünemann AU - Rudolf F. Guthoff AU - Oliver Stachs AU - Thomas Stahnke PY - 2023 JO - Pharmaceutics DO - 10.3390/pharmaceutics15020329 UR - https://doi.org/10.3390/pharmaceutics15020329 ER -
APA
Sterenczak, K. A., Fuellen, G., Jünemann, A., Guthoff, R. F., Stachs, O., & Stahnke, T. (2023). The Antibiotic Kitasamycin—A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?. Pharmaceutics. https://doi.org/10.3390/pharmaceutics15020329
Source records
- crossref · retrieved 2026-09-25T18:58:14.749Z